Earnings Summary

Iradimed Corp’s revenue jumped 26.8% since last year same period to $16.13Mn in the Q2 2023. On a quarterly growth basis, Iradimed Corp has generated 4.23% jump in its revenue since last 3-months.

Iradimed Corp’s net profit jumped 28.97% since last year same period to $4.18Mn in the Q2 2023. On a quarterly growth basis, Iradimed Corp has generated 22.72% jump in its net profits since last 3-months.

Iradimed Corp’s net profit margin jumped 1.71% since last year same period to 25.91% in the Q2 2023. On a quarterly growth basis, Iradimed Corp has generated 17.73% jump in its net profit margins since last 3-months.

Iradimed Corp’s earning per share (EPS) estimates for the current quarter stand at 0.28 - a 12% jump from last quarter’s estimates.

Iradimed Corp’s earning per share (EPS) estimates for the current year stand at 0.28.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Iradimed Corp’s return on assets (ROA) stands at 0.14.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Iradimed Corp’s return on equity (ROE) stands at 0.22.